Tamar Securities LLC Acquires 12,800 Shares of SPDR S&P Biotech ETF $XBI

Tamar Securities LLC grew its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 24.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 65,763 shares of the exchange traded fund’s stock after purchasing an additional 12,800 shares during the period. Tamar Securities LLC owned approximately 0.10% of SPDR S&P Biotech ETF worth $8,018,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. JPMorgan Chase & Co. increased its stake in shares of SPDR S&P Biotech ETF by 27.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock valued at $1,356,582,000 after purchasing an additional 2,900,633 shares during the last quarter. Morgan Stanley grew its position in SPDR S&P Biotech ETF by 8.3% during the 4th quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock worth $1,401,181,000 after acquiring an additional 882,718 shares during the last quarter. Wells Fargo & Company MN grew its position in SPDR S&P Biotech ETF by 75.7% during the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock worth $434,835,000 after acquiring an additional 1,536,122 shares during the last quarter. Bessemer Group Inc. grew its position in SPDR S&P Biotech ETF by 13.5% during the 4th quarter. Bessemer Group Inc. now owns 1,853,232 shares of the exchange traded fund’s stock worth $225,965,000 after acquiring an additional 220,244 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its position in SPDR S&P Biotech ETF by 40.5% during the 3rd quarter. Ameriprise Financial Inc. now owns 1,226,147 shares of the exchange traded fund’s stock worth $122,906,000 after acquiring an additional 353,351 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock opened at $133.79 on Monday. The firm has a market capitalization of $8.54 billion, a P/E ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a twelve month low of $80.90 and a twelve month high of $139.19. The stock’s fifty day simple moving average is $132.63 and its 200 day simple moving average is $127.18.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.